BERWYN, PA — AscellaHealth announced that its CEO and co-founder, Dea Belazi, has been recognized as a winner in the PM360 Elite 100. The award honors leaders who have made significant contributions to the healthcare and life sciences industries. Belazi will be celebrated at the ELITE 100 Awards event on June 18th in New York City.
Belazi attributes this recognition to the entire AscellaHealth team. “This honor truly belongs to the entire AscellaHealth team in recognition of their expertise, dedication, and ongoing work that enables patients with complex, chronic conditions to access specialty pharmaceuticals and novel therapies that enhance clinical outcomes,” says Belazi. “It is gratifying to lead a group of talented professionals who share my commitment to healthcare transformation and improving the processes for getting critical healthcare products from manufacturers to patients while ensuring an efficient flow of funds between payers and pharma.”
The PM360 Elite 100 recognizes exceptional leaders, innovators, transformers, and entrepreneurs in the healthcare sector. Out of more than 500 submissions, only 100 winners are selected by the PM360 editorial staff. Winners are evaluated based on their career accomplishments, testimonials from bosses, clients, and colleagues, and supporting evidence of their impact.
Belazi’s recognition highlights his role in advancing healthcare access and efficiency. Under his leadership, AscellaHealth focuses on improving the delivery of specialty pharmaceuticals and therapies to patients with chronic conditions. This award underscores AscellaHealth’s commitment to transforming healthcare and enhancing patient outcomes.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.